preloader

ELI-LILLY AND COMPANY (INDIA) PVT.LTD.

F.NO. 8 (7)/2007/DP/NPPA-Div.II

GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
NATIONAL PHARMACEUTICAL PRICING AUTHORITY

NEW DELHI, DATED THE 14/02/2007

ORDER

In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (5) of the Table hereto annexed as the retail price/revised retail price, exclusive of excise duty, sales taxes/VAT and local taxes, if any, in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof;

TABLE

 

Sl. No. Name of the Formulation Pack Size Existing Retail Price (Rs.) Retail Price without Excise Duty, Sales Tax/VAT and Local Tax, if any (Rs.)
1 Monocomponent Insulin
Humalog 100 IU/ml
(Insulin Lispro )
Each ml of Insulin Lispro contains
100 IU (3.5mg) Insulin Lispro ( r- DNA
origin) as active ingredient,
Batch No. A263524, Qty.26770 cartridges
3ml Cartridge 419.25 414.46
2 Monocomponent Insulin
Humalog Mix 50 – 100 IU/ml
50% Insulin Lispro and 50% Insulin Lispro
Protamine suspension, r – DNA origin
Batch No. – A257892 / Qty. 11,225 cartridges
3ml Cartridge 455.35 441.10
3 Monocomponent Insulin
Huminsulin Regular 100 IU/ml
(Insulin Human Injection)
Batch No. – A257871 / Qty. 7500 Cartridge
3ml Cartridge 208.94 221.85
4 Monocomponent Insulin
Humalog Pen 100 IU/ml
(Insulin Lispro )
Each ml of Insulin Lispro contains :
100 IU (3.5mg) Insulin Lispro ( r- DNA
origin) as active ingredient,
Batch No. A253908, Qty. 9620 Disposable Pens
3ml Disposable Pen 588.75 581.74
5 Monocomponent Insulin
Huminsulin NPH 40 IU/ml
(Isophane Insulin Human Suspension)
Batch No. – A242057Qty. 17836 vial
10ml Vial 239.29 181.90
6 Monocomponent Insulin
Huminsulin Regular 40 IU/ml
(Insulin Human Injection)
Batch No. – A241504 / Qty. 18174 vial
Batch No. – A242252 / Qty. 18342 vial
10ml Vial 239.29 181.90
7 Monocomponent Insulin
Huminsulin NPH 100 IU/ml
(Isophane Insulin Human Suspension)
Batch No. – A241221Qty. 2545 Cartridge
3ml Cartridge 208.94 221.85
8 Monocomponent Insulin
Huminsulin NPH 100 IU/ml
(Isophane Insulin human Suspension)
Batch No. A254774 / Qty. 1620 Cartridges
3ml Cartridge 208.94 221.85
9 Monocomponent Insulin
Huminsulin 30/70 100 IU/ml
(Isophane Insulin human Suspension)
Batch No. A267511 / Qty.43000 Cartridges
3ml Cartridge 208.94 221.85
10 Monocomponent Insulin
Huminsulin 30/70 100 IU/ml Vial
(30% Neutral Insulin Solution & 70%
Isophane Suspension human)
Batch No. HIM273 / Qty.7800 Vials
10ml Vial 409.92 405.07
11 Monocomponent Insulin
Huminsulin 30/70 100 IU/ml Vial
(30% Neutral Insulin Solution & 70%
Isophane Suspension human)
Batch No. HIM267 / Qty.22080 Vials
10ml Vial 409.92 405.07
12 Monocomponent Insulin
Humalog Mix 25 100 IU/ml
25% Insulin Lispro and 75% Insulin Lispro
Batch No. A263545 / Qty.22500 Cartridges
3ml Cartridge 445.95 441.01
13 Monocomponent Insulin
Humalog 100 IU/ml
(Insulin Lispro)
Batch No. A261719 / Qty.25700 Cartridges
3ml Cartridge 419.25 414.46
14 Monocomponent Insulin
Huminsulin Regular 100 IU/ml
(Insulin Human Injection)
Batch No. – A257871 / Qty. 5000 Cartridge
3ml Cartridge 208.94 221.85
15 Monocomponent Insulin
Humalog 100 IU/ml
(Insulin Lispro )
Each ml of Insulin Lispro contains
100 IU (3.5mg) Insulin Lispro ( r- DNA
origin) as active ingredient,
Batch No. A268235, Qty.7500 cartridges
3ml Cartridge 419.25 415.33
  1. This order shall be applicable if the manufacturer of the formulation specified in column (2) of the Table above has complied with the requirements, if any, of

(a)         the Drugs and Cosmetics Act, 1940 (23 of 1940) and the rules made thereunder; and

(b)         the Industries (Development and Regulation) Act, 1951 (65 of 1951) as amended from time to time.

3.(a)     Excise Duty, sales taxes/VAT and local taxes, if any, shall be worked out by the company concerned as per the rate applicable and added in the retail price / revised retail price specified in column no (5) of the above table to arrive at the MRP inclusive of all taxes.

(b)     The prices fixed/revised is the Maximum Retail Prices (excluding of excise duty, sales taxes/VAT and of local taxes, if any) for the specified pack and packs of similar strength. Companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(c)        For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

  1. These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.

(A. K. PAL)
Dy. Director

PN/91/2007/F
M/s. Eli-Lilly and Company (I) Pvt. Ltd.

Last Page Updated: 30-10-2018